top of page

Iron-Sulphur (FeS) Clusters:
from Chemistry to Immunology

A Pan-European Research Network to Push the Frontiers in Bioinorganic Chemistry & Immunology/Virology

Action logo-revised-adj.png

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Find out more at COST website

This website is based upon work from COST Action FeSImmChemNet, supported by COST (European Cooperation in Science and Technology)

Let the Science
Cross Boundaries

We support networking activities to provide equal opportunities for scientists across Europe.  

Scientific Meetings

We organize a yearly meeting bringing together scientists across Europe with a specific focus on Early Career Researchers and Innovators. Read more here

Access to Research Facilities

We support mobility of scientists to access research facilities and infrastructure across Europe. Read more here

Scientific Mobility

We award short-term scientific mission awards allowing researchers from one member country to visit another for a duration of up to 3 months to learn new techniques and perform experiments. Read more here

Training Schools

We organize summer training schools (2-3 days) for Early Career Researchers and Innovators to strengthen the research skills across Europe and help train the next generation of leaders. Read more here

Action in Numbers


Date Started


Countries Invovled


ITC countries & Near Neighbor Countries





Our Expertise

Immunology & Virology
Spectroscopy of Metalloproteins
Structural Biology
Metabolomics & Metallomics
Medicinal & Computational Chemistry

Are you studying the roles of metals in biology? Do you use different biophysical and cell biological tools to study the roles of metals in biology? Does your research focus on the immune system and viral infection? Are you interested in developing new therapeutics?

bottom of page